Condition
NYHA Class III Heart Failure clinical trials and research
As of November 12, 2026, Find a Trial lists 2 NYHA Class III Heart Failure clinical trials that are recruiting, in United States. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
NORM-HF: A new system to help manage moderate to severe heart failure
This test will see if using the FIRE1 NORM system with guided heart failure care helps people with NYHA class II–III heart failure stay out of trouble more than standard care.
-
Comparing cardiac contractility modulation (CCM) to usual care for people with reduced ejection fraction and NYHA class III heart failure
This study tests whether cardiac contractility modulation (CCM) reduces deaths and heart failure hospital stays in Medicare‑eligible adults with NYHA class III heart failure and an ejection fraction of 25–45%.
Related topics
Quick answers
How many NYHA Class III Heart Failure clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.